Authors


David B. Nelson, MD

Latest:

How can we prevent pregnancy-related deaths?

Interventions before and after birth can reduce the rising maternal mortality ratio.


Christopher M. Zahn, MD

Latest:

Designing your patient’s prenatal care “PATH”

Recommendations for maternity care professionals based on MiPATH.


Connor Iapoce

Latest:

Socioeconomic factors linked to postpartum anemia prevalence

A meta-analysis of over 1 million pregnant women in China reveals a 30% anemia prevalence, with significant variations across regions, urban and rural areas, and trimesters.


Ericka Podesta McCoy

Latest:

Bridging the gap: Unlocking women's health care potential

Despite a $350 billion market potential for menopause treatment, a disconnect persists between women and health care providers, highlighting the need for personalized, trust-building strategies.


Halley Crissman, MD, MPH

Latest:

How health care systems and providers can address cisnormativity

Halley Crissman, MD, MPH, shares her insight on the ways in which hospital systems reinforce cisnormativity and focal points to address for a more welcoming environment.


Michael Blackman, MD

Latest:

Financial success and patient satisfaction: Are they related?

When considering the “health” of a medical practice, much of the focus is on financial indicators: missing collections at the time of service, recurring denials, poor claims management and aging patient balances. However, another area needs attention but is often overlooked: patient satisfaction.


Elaine Duryea, MD

Latest:

Protocol 11: Maternal Anemia

The protocol presented here provides an algorithm for the initial evaluation of anemia in pregnancy, with treatment algorithms for the most common causes in pregnancy.


Christine Blank

Latest:

Pharmacies limiting Plan B purchases after Roe v. Wade reversal

The American Medical Association is urging the FDA to approve OTC access to oral contraceptives.


Audrey K. Rutherford, MD

Latest:

Essentials of vulvovaginal dermatology

Correct terms and education can help normalize the conversation for patients.


Lauren Massaro

Latest:

Later-onset menopause linked to higher asthma risk

Women experiencing menopause later in life may face an increased risk of asthma, according to recent research highlighting the impact of hormone levels on respiratory health.


Tina Foster, MD, MPH, MS

Latest:

Why shared decision-making matters more than ever

Sweeping policy-level implementation efforts have mandated SDM in other areas of medicine; similar mandates could impact ob/gyn.


Erin Roesch, MD

Latest:

Dynamic treatment for early-stage triple-negative breast cancer

Standard chemotherapy has historically been the mainstay of treatment for patients with diagnoses of early-stage TNBC, but there remains an unmet need to identify novel therapies that improve outcomes and, equally important, to discern which patients may benefit from a given treatment.



David D. Rahn, MD

Latest:

Urodynamics and the role of lidocaine

Explore the potential benefits and considerations of utilizing intraurethral lidocaine jelly during urodynamic studies for bladder testing, as we delve into research findings on patient discomfort, voiding metrics, and diagnostic precision.


Thomas C. Wright Jr, MD

Latest:

Key Takeaways for HPV and Cervical Cancer Screening

Drs Emily K. Hill, Sangini S. Sheth, and Mark H. Stoler share practice pearls for HPV and cervical cancer screening and express their hope for emerging testing options.



Sangini S. Sheth, MD, MPH

Latest:

Deep dive into HPV vaccines

A safety and efficacy refresher


Marco Meglio

Latest:

No evidence of elevated MS relapse risk following fertility treatments

Among 43 cycles that achieved pregnancy, investigators observed decreases of annualized relapse rates from 0.26 to 0.09.


R. Todd Ivey, MD

Latest:

Texas Senate Bill 8 (SB 8): NOT just another anti-abortion bill

On May 19, 2021, Governor Greg Abbott signed Texas Senate Bill 8 (also known as the Fetal Heartbeat Bill) into law with the statement that this will save lives in the state of Texas. This law is recognized as the most restrictive anti-abortion regulation in the United States today.


Urology Times staff

Latest:

AI vs. human: A comparative study on summarizing incontinence research

Mubashir S. Billah, MD, discusses a study presented at the 2024 AUA Annual Meeting, which evaluates the efficacy of AI-generated summaries against traditional human-written summaries in the field of incontinence research.


John Parkinson

Latest:

HIV Roundtable: Examining aging with HIV, multidrug resistance, and vaccine development

In this episode, clinicians discuss challenges associated with these topics and offer some insights on them.


Christine Payne

Latest:

Finding the best fit

Best practices on discussing birth control for adolescents.


Linda L. Fan, MD

Latest:

Linda Fan, MD, on telehealth in the second stage of COVID-19

In this video interview, Senior Editor Angie DeRosa talks with Linda Fan, MD, about the rise of telehealth as the pandemic enters the second stage.


Linda Giudice, MD PhD

Latest:

Endometriosis: Surgery and GnRh Agonists

Sawsan As-Sanie, MD, Jessica Shim, MD, Robert Taylor, MD, PhD, and Linda Giudice, MD, PhD, discuss the role of surgery and GnRh agonists for the treatment of endometriosis.


Janelle Hart

Latest:

YouTube spreads low-quality medical information on recurrent UTIs, study shows

In today’s world, it is easy to find information on the internet, whether it be through search engines or social media. Much of that information, however, is not reliable.


Jeffrey A. Kuller, MD

Latest:

SMFM Consult Series #57: Evaluation and management of soft ultrasound markers for aneuploidy

In this consult series, experts from SMFM discuss the evaluation and management of soft ultrasound markers for aneuploidy.



Seema A. Khan, MD

Latest:

Contemporary understanding of breast cancer risk with combined oral contraceptives

Unveiling the intricate relationship between combined oral contraceptive use and breast cancer risk, navigating through research insights and clinical implications for informed patient counseling.


Kyle Doherty

Latest:

Lenvatinib plus pembrolizumab displays efficacy in advanced endometrial cancer

The combination of lenvatinib plus pembrolizumab induced durable responses with a manageable safety profile in adults with previously treated, advanced endometrial cancer, according to a long-term follow-up analysis of a phase 1b/2 study (NCT02501096).


Danielle T. Cipres, MD

Latest:

How to identify common pediatric vulvar conditions

Understanding signs, symptoms helps determine the best treatment regimen

© 2024 MJH Life Sciences

All rights reserved.